Torvergata Oncoscience Research (TOR) is an inter-Departmental research centre of excellence within the University of Rome Tor Vergata. TOR has the ambition to promote internationally competitive research in oncology creating a hub which will enhance leadership and visibility of Rome in the international landscape. The centre will facilitate interaction between local and international science, contributing to the development of the local clinical and academic community in oncology. It aims to stand a central position in the international network of all European and international research cancer Institutes interested in scientific collaboration.

Gerry Melino, Director of the TOR Centre, is Professor of Biochemistry at the University of Rome Tor Vergata. Member of Accademia Lincei & Accademia Europaea, he is Founder & Editor-in-Chief of Cell Death Differentiation, Cell Death Disease and Cell Death Discovery journals.